An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab

BACKGROUND: Cell-based assays for neuromyelitis optica (NMO) diagnosis are the most sensitive and specific methods to detect anti-aquaporin 4 (AQP4) antibodies in serum, but some improvements in their quantitative and specificity capacities would be desirable. Thus the aim of the present work was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez Gomar, Ismael, Díaz Sánchez, María, Uclés Sánchez, Antonio José, Casado Chocán, José Luis, Ramírez-Lorca, Reposo, Serna, Ana, Villadiego, Javier, Toledo-Aral, Juan José, Echevarría, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096525/
https://www.ncbi.nlm.nih.gov/pubmed/24980919
http://dx.doi.org/10.1186/1471-2377-14-139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096525/
https://www.ncbi.nlm.nih.gov/pubmed/24980919
http://dx.doi.org/10.1186/1471-2377-14-139

Ejemplares similares